Colder Weather May Bring Added Discomfort For Raynaud's Sufferers PDF Print E-mail
Tuesday, 17 November 2009 14:02
taken from http://www.flickr.com/photos/denisecarbonell/3269836335/ via creative commonsColder weather triggers a painful and sometimes debilitating disorder for many who suffer from Raynaud's disease. Raynaud's is an autoimmune disorder in which spasms in the blood vessels can interrupt blood flow to the fingers, toes, nose and ears. Exposure to cold triggers the spasms, typically causing the affected area to turn white, then blue, then bright red. Emotional stress can also cause an attack.

During an attack, Raynaud's sufferers experience tingling, swelling or painful throbbing. Episodes may last from minutes to hours. In severe cases, the area may develop ulcerations and infections.

According to the Raynaud's Association, only one out of five sufferers seeks treatment. Both men and women suffer from Raynaud's, but women are nine times more likely to be affected. "Some researchers estimate as many as 20 percent of all women in their childbearing years have Raynaud's," says Lynn Wunderman, chair of the Raynaud's Association.

"Too many Raynaud's sufferers dismiss their symptoms as being due to 'poor circulation,'" Wunderman says. "In a sense that's true, but there's a medical cause for their poor circulation -- and sometimes it can be serious."

In some cases, Raynaud's symptoms may indicate a serious underlying disorder such as Scleroderma, lupus or rheumatoid arthritis. Robert Riggs, CEO of the Scleroderma Foundation, notes that more than 90 percent of people diagnosed with systemic scleroderma also have Raynaud's. "In most of these cases, Raynaud's is the first symptom."

These patients are considered to have "secondary Raynaud's," meaning another associated disease is present. Fortunately, however, most Raynaud's sufferers have the more benign "primary" form. The Raynaud's Association and the Scleroderma Foundation advise individuals with symptoms to consult with their physicians, who can perform simple blood tests to determine whether or not antibodies associated with other diseases are present. Rheumatologists -- physicians who specialize in the diagnosis and treatment of arthritis, Raynaud's and diseases of the joints, muscles and bones -- may be consulted.

At this time there is no cure for Raynaud's, although research is underway. In the meantime, sufferers are advised to avoid cold temperatures as much as possible, effect lifestyle changes and protect the affected extremities with gloves, hats and other such measures. "Obviously, winter presents the biggest challenges," says Wunderman. So, should Raynaud's sufferers move south for the winter? "Well," she concludes, "that might help somewhat, if you can avoid all of those frigid air conditioned places -- not an option for many sufferers in their daily lives."

This article was taken in part from the PR Newswire. For a link to the orginal  article, click here. To find out more about Raynaud's, click here for our previous article, and do visit the Raynaud's Association for more... and do remember to stay warm.
 
More articles :

» Restoring Alkalinity in the Body

All foods are "burned" within the body, leaving an ash as the result of the "burning" or digestion. This food ash can be neutral, acid or alkaline, depending largely on the mineral composition of the foods.Some foods leave an acid residue or ash,...

» Rheumatologist Receives Scleroderma Foundation's Lifetime Achievement Award

In a recent article, it was reported that ,  Gerald P. Rodnan Professor of Medicine, , received the 's Lifetime Achievement Award in recognition of his service to the community. The award is the foundation's highest honor and is presented to...

» Preliminary Results Show Beneficial Effects of Imatinib in Scleroderma

Imatinib (Gleevec), a drug that has significantly improved survival in chronic myelogenous leukemia and gastrointestinal stromal tumor, is showing beneficial effects on skin and lung manifestations in patients with diffuse cutaneous scleroderma....

» Juvenile Localized Scleroderma: Fewer Flares With Methotrexate

was an effective and well-tolerated treatment for in a randomized, double-blind, placebo-controlled trial involving 70 patients with active disease. At the end of the 12-month study, 31 of 46 patients randomized to receive methotrexate had...

» Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases

Stephen C. Mathai, Laura K. Hummers, Hunter C. Champion, Fredrick M. Wigley, Ari Zaiman, Paul M. Hassoun, and Reda E. GirgisObjective. Pulmonary hypertension (PH) is an important cause of mortality in systemic sclerosis (SSc), where it can be...

» March Designated as 'National Autoimmune Diseases Awareness Month' in the U.S.

On the evening of March 4, 2010, the U.S. Senate passed a resolution designating March as "National Autoimmune Diseases Awareness Month" and supporting efforts to increase awareness of autoimmune diseases and increase funding for autoimmune disease...